Sexual dysfunction high among women with lung cancer

NRG Oncology adds new committee leaders in lung cancer and imaging

Kristin HigginsKarthik SundaramKristin Higgins and Karthik Sundaram were named chairs of NRG Oncology’s Lung Cancer Committee and Imaging Committee.

May 09, 2025

Vol.51 No.18

Clinical Roundup

UC Lung Cancer Consortium and AstraZeneca partner to improve early lung cancer detection

The University of California Lung Cancer Consortium and AstraZeneca announced a five-year partnership to expand the Healthy Lungs California initiative, which is aimed at increasing early lung cancer detection and reducing deaths from the disease.

May 02, 2025

Vol.51 No.17

Clinical Roundup

Lung-MAP trial for NSCLC expands genomic screening options for patients

Most patients who enroll in the Lung-MAP precision medicine trial in non-small cell lung cancer can now be matched to a targeted investigational treatment based on the results of their prior genomic testing, without needing to submit new tumor or blood samples.

April 18, 2025

Vol.51 No.15

In Brief

University Hospitals Cleveland, Qure.ai collaborate on early lung cancer detection

University Hospitals Cleveland Medical Center has announced a collaboration with global healthcare AI company Qure.ai to deploy chest X-ray AI supporting earlier identification of lung cancers.

April 04, 2025

Vol.51 No.13

Clinical Roundup

Mass General study: Screenings for breast and colorectal cancer 4x higher than lung cancer

Although lung cancer screening is recommended in the U.S. for certain individuals with a history of smoking, only 18% of eligible individuals in the U.S. get screened.

April 04, 2025

Vol.51 No.13

Drugs & Targets

CHMP recommends approval for Tevimbra as a first-line treatment for extensive-stage small cell lung cancer

BeiGene Ltd. announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency issued a positive opinion recommending approval of Tevimbra (tislelizumab), in combination with etoposide and platinum chemotherapy, as a first-line treatment for adult patients with extensive-stage small cell lung cancer.

April 04, 2025

Vol.51 No.13

Sexual dysfunction high among women with lung cancer

YOU MAY BE INTERESTED IN

NRG Oncology adds new committee leaders in lung cancer and imaging

UC Lung Cancer Consortium and AstraZeneca partner to improve early lung cancer detection

Lung-MAP trial for NSCLC expands genomic screening options for patients

University Hospitals Cleveland, Qure.ai collaborate on early lung cancer detection

Mass General study: Screenings for breast and colorectal cancer 4x higher than lung cancer

CHMP recommends approval for Tevimbra as a first-line treatment for extensive-stage small cell lung cancer

Renew today!

Subscriber content

Never miss an issue!

Login